Moderna, Inc. Logo

Moderna, Inc. (0QF)

FSX

Currency in EUR
125.30
+12.90 (+11.48%)

Closed

Aug 21, 2026

Day's Range

111.00
135.70

52 wk Range

19.26
151.14

Overview - 0QF - Moderna, Inc.

Key Statistics

Valuation

Enterprise Value

35.04B

P/E (Trailing)

‪25.27‬

PEG Ratio

‪-3.36‬

Price / Sales (TTM)

‪21.50‬

Price / Book

‪8.26‬

EV / EBITDA

‪-18.68‬

Profitability

Gross Margin

‪34.96%‬

Profit Margin

‪-141.42%‬

Operating Margin

‪-557.93%‬

Return on Assets

‪-13.25%‬

Return on Equity

‪-38.99%‬

Ownership

Shares Outstanding

399.00M

Float

372.26M

Held by Insiders

‪7.31%‬

Held by Institutions

‪80.46%‬

Price stats

Beta

‪0.89‬

50-Day Avg

‪58.05‬

200-Day Avg

‪42.20‬

Dividends

Payout Ratio

‪0.00%‬

Market Cap - 0QF - Moderna, Inc.

Peers - 0QF - Moderna, Inc.

Peer Comparison

Compared with companies in Biotechnology listed on FSX.

Profile Summary - 0QF - Moderna, Inc.

About

Moderna, Inc. is a biotechnology company specializing in the research, development, and provision of messenger RNA (mRNA) medicines in the United States, Europe, and internationally. Its primary function centers on creating innovative therapeutics and vaccines using mRNA technology, targeting a broad spectrum of…

SectorHealthcare
IndustryBiotechnology
Employees4.70K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.